Publications: Stephen Ezell
March 30, 2026
Mobilizing for Techno-Economic War, Part 2: Slowing China’s Advance
Boosting U.S. competitiveness in national power industries is necessary, but not sufficient to avoid losing to China. America also must take measures to slow the PRC’s progress toward global dominance. This report provides more than 100 actionable recommendations for the administration and Congress. Western allies should take many of the same steps.
March 23, 2026
Assessing the Evolving Global Competitiveness of the US Auto Industry
To win the techno-economic competition with China, America must be able to assess the factors impacting the global competitiveness of its advanced-technology industries. Using the auto industry as a template, U.S. competitiveness has faltered considerably.
March 18, 2026
Comments to the US Treasury Department Regarding the CFIUS Known Investor Program and Foreign Investment Review Process
CFIUS’ procedures need to be strengthened to ensure that Chinese entities, particularly those influenced or backed by Chinese government influence or funding, cannot acquire U.S. companies or technology that could harm America’s economic or national security.
March 18, 2026
Lessons From Europe’s Loss of Biopharma Leadership, and Its Attempts to Recover
Europe once led the world in biopharmaceutical innovation, but it lost ground after adopting policies that weakened incentives for R&D and innovation. America must learn from Europe’s experience to preserve its own biopharma leadership and the related economic benefits and access to the most innovative drugs.
March 17, 2026
Testimony to the House Ways and Means Trade Subcommittee Regarding Advancing America’s Interest at the WTO’s 14th Ministerial Conference
The United States should use MC14 to push for a WTO that actively promotes fair market competition—not one that passively accepts non-market policies, overcapacity, and coercive distortions that are undermining the global trading system.
February 23, 2026
Comments to Department of Health and Human Services Regarding the Proposed GUARD Model
The international reference pricing-based GUARD model lacks a sound premise for its rationale, is fundamentally flawed in its design, and should be withdrawn in full by CMS.
February 23, 2026
Comments to Department of Health and Human Services Regarding the Proposed GLOBE Model
The international reference pricing-based GLOBE model lacks a sound premise for its rationale, is fundamentally flawed in its design, and should be withdrawn in full by CMS.
January 22, 2026
Trump Is Correct: European Nations Must Pay More for Innovative Drugs
Europe has long free-ridden on U.S. drug innovation—and while President Trump is right to push allies to pay their fair share, importing Europe’s price controls into the U.S. would undercut the very innovation the world depends on.
January 5, 2026
Top 10 Tech Policy Pronouncements, Prognostications, and Questions for 2026
If the year ahead in technology and innovation policy lives up to its potential, it could be a consequential one because there is a long list of important issues on the table. Herein, we offer 10 that are on top of our minds.
December 18, 2025
Comments to OSTP Regarding Accelerating the American Scientific Enterprise
The science community must move beyond the linear model of scientific research developed and encouraged by Vannevar Bush, and realign scientific exploration with national interests, especially in the face of the growing technological and economic threat posed by China.
